Oral Orladeyo Now Available in UK to Treat HAE Swelling Attacks

Oral Orladeyo Now Available in UK to Treat HAE Swelling Attacks

306648

Oral Orladeyo Now Available in UK to Treat HAE Swelling Attacks

Orladeyo (berotralstat), a daily oral therapy to prevent swelling attacks in people with hereditary angioedema (HAE), is now available in England, Wales, and Northern Ireland for eligible patients ages 12 and older. That authorization came as the U.K.’s National Institute for Health and Care Excellence (NICE) recommended Orladeyo — marketed by BioCryst Pharmaceuticals — as a treatment for people with HAE who have at least two swelling attacks per month. The Scottish Medicines Consortium (SMC) is…

You must be logged in to read/download the full post.